STOCK TITAN

Denali Cap Acqsn SEC Filings

DECAU NASDAQ

Welcome to our dedicated page for Denali Cap Acqsn SEC filings (Ticker: DECAU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Denali Capital Acquisition Corp. (historically linked to the Nasdaq unit symbol DECAU) files a range of documents with the U.S. Securities and Exchange Commission that outline its structure and progress as a blank check company. These SEC filings are central for understanding its units, Class A ordinary shares, warrants, listing status, and efforts to complete a business combination.

Among the key filings are Form 8-K current reports, which describe material events such as deposits into the company’s trust account to extend the deadline for consummating a business combination by one month at a time. Other Form 8-K filings provide detail on the agreement and plan of merger involving Denali Capital Acquisition Corp., Denali Merger Sub Inc., and Semnur Pharmaceuticals, Inc., including amendments that adjust definitions of the exchange ratio and merger consideration while maintaining a 1.25-to-1 exchange ratio.

A Form 25 filed by Nasdaq Stock Market LLC serves as the notification of removal from listing and/or registration under Section 12(b) of the Securities Exchange Act of 1934 for Denali Capital Acquisition Corp.’s Class A ordinary shares, units, and warrants. This document confirms that the securities were removed from listing on Nasdaq, while later Form 8-K filings indicate that the units, shares, and warrants trade on OTC markets under the symbols DNQUF, DNQAF, and DNQWF.

The company has also submitted a Form 12b-25 (Notification of Late Filing) explaining a delay in filing a Quarterly Report on Form 10-Q due to the time required to complete financial statements and disclosures, and stating that it expected to file within the permitted extension period. Together, these filings provide a detailed regulatory record of Denali Capital Acquisition Corp.’s capital structure, listing changes, deadline extensions, and proposed business combination, and they can be reviewed alongside AI-powered summaries that clarify the significance of each document.

Rhea-AI Summary

Denali Capital Acquisition Corp. (Nasdaq: DECAU) has filed Form 25 with the U.S. Securities and Exchange Commission, signaling the removal of its Class A Ordinary Shares, Units and Warrants from listing and registration on the Nasdaq Stock Market LLC.

The filing, dated 14 July 2025 and signed by a Nasdaq Hearings Advisor, states that the Exchange "has complied with its rules to strike the class of securities from listing and/or withdraw registration." The notice cites Rule 12d2-2 under the Securities Exchange Act of 1934, indicating that the procedural requirements for delisting or voluntary withdrawal have been satisfied.

No financial metrics, earnings data, or reasons for the delisting are provided in the document. The Form 25 serves as official notification that, once effective, the securities will no longer be traded on Nasdaq or registered under Section 12(b) of the Exchange Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration

FAQ

What is the current stock price of Denali Cap Acqsn (DECAU)?

The current stock price of Denali Cap Acqsn (DECAU) is $11.84 as of February 21, 2025.

DECAU Rankings

DECAU Stock Data

8.41M
Pharmaceutical Preparations
US
NEW YORK

DECAU RSS Feed